𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy

✍ Scribed by Charles M. Nicolet; Jean M. Surfus; Jacquelyn A. Hank; P. M. Sondel

Book ID
105968314
Publisher
Springer-Verlag
Year
1998
Tongue
English
Weight
704 KB
Volume
46
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adoptive immunotherapy with lymphokine-a
Adoptive immunotherapy with lymphokine-activated killer cells plus recombinant interleukin 2 in patients with unresectable hepatocellular carcinoma
✍ Saburo Onishi; Toshiji Saibara; Masanao Fujikawa; Hiroshi Sakaeda; Yasushi Matsu πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

Ten patients with hepatocellular carcinoma, three of whom had pulmonary metastasis, were treated with adoptive immunotherapy using autologous lymphokineactivated killer cells plus recombinant interleukin 2. Patients received 16 pg per day of recombinant interleukin 2 consecutively (for 14 to 64 days

Lymphokine-activated killer cell functio
Lymphokine-activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma
✍ Shinya Arinaga; Nobuya Karimine; Shigeru Nanbara; Hiroshi Inoue; Hideaki Nakashi πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 635 KB

Lymphokine-activated killer (LAK) cells generated by culture of regional lymph node cells (LNC) with interleukin 2 (IL 2) for 4 and 11 days were examined for their functional capabilities in comparison with those of peripheral blood mononuclear cells (PBM) in 25 patients with gastric carcinoma. The